The FDA has approved Epioxa™ HD 0.239% and Epioxa™ 0.177% for use in epithelium-on corneal collagen CXL for the treatment of ...

The Food and Drug Administration has approved Eydenzelt (aflibercept-boav), a biosimilar to Eylea (aflibercept).

Pilocarpine 1.25% can boost distance corrected near visual acuity among other measures, in presbyopic adult eyes with dark irides.

Multifocal intraocular lenses may offer patients with mild-to-moderate glaucoma greater spectacle independence.

Increasing use of social media throughout early adolescence is significantly associated with lower performance in specific aspects of cognitive function.

Older adults with visual impairment are significantly more likely to have difficulty leaving their homes, research shows.

Implementation of a new definition of obesity yields a substantial increase in the prevalence of obesity. HealthDay News — Implementation of a new definition of obesity yields a substantial increase ...

For cancer survivors, postdiagnosis smoking cessation is associated with improved overall survival. HealthDay News — For cancer survivors, postdiagnosis smoking cessation is associated with improved ...

Health professionals are screening and advising fewer than half of youth about tobacco use. HealthDay News — Health professionals are screening and advising fewer than half of youth about tobacco use, ...

The presence of IBD among patients with axSpA was not linked to an increased risk for active axSpA or radiographic progression.

Use lifestyle interventions to show no signs of type 2 diabetes for at least three months? HealthDay News — Use lifestyle interventions to show no signs of type 2 diabetes for at least three months?

The U.S. Food and Drug Administration (FDA) has cleared another blood test that could help doctors identify whether a patient’s memory problems are likely caused by Alzheimer’s disease.